ESC 2024 Guidelines on Aortic Aneurysm Classification and Management

1. Classification of Aortic Aneurysms

• The ESC classifies aortic aneurysms by anatomic location (thoracic vs. abdominal), etiology (degenerative, genetic, inflammatory, infectious, traumatic), morphology (fusiform vs. saccular), and size thresholds that are adjusted for sex and body habitus, with additional high‑risk features beyond diameter influencing rupture risk. [1][2]3

• Thoracic aortic aneurysms (TAAs) are further subdivided:
  
  • Aortic root aneurysms account for ~60 % of TAAs, involve the sinuses of Valsalva, occur in younger adults (≈30–50 years) with a roughly equal sex distribution, and are linked to heritable thoracic aortic disease or bicuspid aortic valve in 20–30 % of cases. [2][3]
  • Supra‑coronary (ascending) aneurysms are seen in older adults (≈60–70 years) with a 3:1 male predominance and arise from atherosclerosis/hypertension or medial degeneration. [2][3]
  • Aortic arch aneurysms represent ~10 % of TAAs, usually coexist with adjacent ascending or descending aneurysms, are predominantly atherosclerotic, and carry heightened neurological and cardiovascular surgical risk. 2
  • Descending thoracic aneurysms comprise ~30 % of TAAs, are mainly degenerative with calcification, but may also result from trauma, infection, inflammation, or genetic factors. 2
• Infrarenal abdominal aortic aneurysms (AAAs) represent two‑thirds of all AAAs, are often discovered incidentally on imaging, and may present with acute abdominal/back pain or hypovolemic shock when ruptured. 1

2. Etiologic Categories

• Degenerative/atherosclerotic disease is the dominant cause of TAAs (~80 %), driven by hypertension and affecting older adults. [2][3]
• Genetic/heritable thoracic aortic disease accounts for ~20 % of TAAs and includes both syndromic (e.g., Marfan, Loeys‑Dietz) and non‑syndromic forms; genetic evaluation is recommended based on age, family history, and syndromic features. [2][3]
• Bicuspid aortic valve‑associated aneurysms occur in 20–30 % of patients with a bicuspid valve, most often involving the aortic root. [2][3]
• Inflammatory aortitis (e.g., Takayasu’s arteritis, giant‑cell arteritis) is a rare cause of aneurysm formation. [2][3]
• Infectious (mycotic) aneurysms arise from bacterial infection; syphilitic involvement is now uncommon. [2][3]
• Traumatic aneurysms result from blunt deceleration injuries or coarctation‑related mechanisms. [2][3]

3. Morphologic Considerations

• Saccular aneurysms (focal outpouchings) are frequently linked to penetrating atherosclerotic ulcers and constitute a high‑risk feature for rupture, independent of diameter. 2

4. Size‑Based Definitions

• Aortic dilatation is defined as a diameter > 2 standard deviations above the predicted mean (z‑score > 2), adjusted for age, sex, and body size. 3
• Aortic root dilatation thresholds in clinical practice: > 40 mm in males, > 36 mm in females, or an aortic size index (ASI) > 22 mm/m². 3
• Aneurysm is defined as a diameter > 1.5 times the predicted normal value (≥ 50 % increase), corresponding to z‑score > 2. 3
• The aortic height index (AHI) is preferred over BSA‑based correction because it avoids underestimation in overweight patients. 3
• The ESC recommends using the term “significant aortic dilation” with explicit diameter values rather than “aneurysm,” since surgical indications often arise before classic aneurysmal dimensions are reached. [2][3]

5. Intervention Thresholds (by Location & Sex)

• Thoracic aorta (root/ascending) with tricuspid aortic valve: elective surgery recommended at ≥ 55 mm. Class I. 4
• Thoracic aorta (root/ascending) with bicuspid aortic valve: consider surgery at lower diameters when high‑risk features are present. Class I. [1][4]
• Aortic arch aneurysm: surgery should be considered at ≥ 55 mm. Class I. 4
• Abdominal aortic aneurysm in women: consider repair at 45–50 mm. Class I. [1][4]
• Abdominal aortic aneurysm in men: consider repair at 50–55 mm. Class I. [1][4]

6. High‑Risk Features Beyond Diameter

Thoracic Aortic Aneurysms

• Saccular morphology with penetrating atherosclerotic ulcer.
• Uncontrolled resistant hypertension.
• Rapid growth ≥ 3 mm/year for the ascending aorta or arch.
• Patient‑specific factors: age < 50 years, height < 1.69 m, ascending length > 11 cm, root‑type phenotype, bicuspid valve with coarctation, family history of acute aortic events.
• Indexed measurements (ASI or AHI) that relate size to patient height/body size improve risk stratification.

Abdominal Aortic Aneurysms

• Rapid expansion ≥ 10 mm/year or ≥ 5 mm within 6 months.
• Women have a four‑fold higher rupture risk than men at equivalent diameters.

• Radiological signs of impending rupture: retroperitoneal hematoma, contrast extravasation, high‑crescent sign, periaortic fat stranding, tangential calcification, discontinuous calcification, thrombus fissuration, draped aorta sign.

  [1][2]

7. Surveillance Intervals

Abdominal Aortic Aneurysm

[1][4]

Thoracic Aortic Aneurysm

• 40–44 mm: baseline CCT/CMR, repeat transthoracic echo in 1 year.
• 45–49 mm: confirm size with CCT/CMR.
• ≥ 50 mm: confirm with CCT/CMR; if growth ≥ 3 mm/year, assess high‑risk features and consider repair.

1

8. Imaging Modality Recommendations

• Duplex ultrasound is the standard modality for AAA surveillance. Class I. [1][4]
• Contrast‑enhanced CT (CCT) or cardiac MRI (CMR) is recommended when duplex ultrasound cannot provide adequate measurement. Class I. [1][4]
• CMR is reasonable for long‑term follow‑up in younger or female patients to avoid radiation exposure. Class IIa. 1

9. Key Clinical Pitfalls

• Reliance on physical examination alone for AAA detection is inadequate because palpation has poor sensitivity. Class I. 1
• Women require lower intervention thresholds (≈ 45 mm) compared with men (≈ 50 mm) due to a markedly higher rupture risk at comparable diameters. Class I. 1
• Body‑surface‑area indexing underestimates risk in overweight patients; the aortic height index should be used instead. Class I. 3
• Rapid aneurysm growth (≥ 3 mm/year for TAAs; ≥ 10 mm/year or ≥ 5 mm in 6 months for AAAs) mandates consideration of repair regardless of absolute diameter. Class I. [1][2]
• Presence of saccular morphology with a penetrating atherosclerotic ulcer confers high rupture risk independent of size. Class I. 2

Classification and Risk Stratification of Aortic Aneurysms

Anatomic Classification

• Thoracic aortic aneurysms (TAAs) are divided by segment: aortic root (≈60% of TAAs), supra‑coronary ascending aorta, aortic arch (≈10% of TAAs), descending thoracic aorta (≈30% of TAAs), and thoraco‑abdominal aortic aneurysms (TAAAs) that span the thoracic and abdominal aorta. The ESC 2024 Guidelines define this anatomic framework. 5

• Aortic root aneurysms involve the sinuses of Valsalva, are most common in younger adults (≈30–50 years) with equal sex distribution, and are frequently linked to heritable thoracic aortic disease or bicuspid aortic valve (20–30% of cases). 5

• Supra‑coronary (ascending) aortic aneurysms occur above the sinuses, are predominantly caused by atherosclerosis and hypertension in older adults (≈59–69 years) with a 3:1 male predominance, and may also result from medial degeneration. 5

• Aortic arch aneurysms (≈10% of TAAs) often coexist with adjacent ascending or descending aneurysms, are usually atherosclerotic, and pose heightened neurological and cardiovascular surgical risk. 5

• Descending thoracic aortic aneurysms (≈30% of TAAs) are mainly degenerative with calcification; trauma, infection, inflammation, or genetic factors can also contribute. 5

• Thoraco‑abdominal aortic aneurysms (TAAAs) extend from the descending thoracic aorta into the abdominal aorta and are classified for endovascular planning by landing zones numbered 0–11. 6

Etiologic Classification

• Degenerative/atherosclerotic disease is the most common cause of TAAs, associated with hypertension in ~80% of cases and predominating in older patients. 5

• Genetic/heritable thoracic aortic disease accounts for ~20% of TAAs and includes both syndromic (e.g., Marfan, Loeys‑Dietz) and non‑syndromic forms. 5

• Bicuspid aortic valve–associated aneurysms occur in 20–30% of patients with a bicuspid valve, typically affecting the aortic root. 5

• Inflammatory aortitis (e.g., Takayasu’s arteritis, giant‑cell arteritis) represents a rare etiologic group. 5

• Infectious (mycotic) aneurysms are caused by bacterial infection; historic syphilitic involvement is now uncommon. 5

• Traumatic aneurysms arise from blunt deceleration injuries or are related to coarctation of the aorta. 5

Morphologic Classification

• Fusiform aneurysms (circumferential dilation) are the predominant shape of aortic aneurysms. 7

• Saccular aneurysms (focal outpouching) are often linked to penetrating atherosclerotic ulcers and constitute a high‑risk feature for rupture. 5

Size‑Based Definition

• An aortic aneurysm is defined as a diameter >1.5 times the predicted normal value (i.e., >50 % larger), adjusted for age, sex, and body size, corresponding to a z‑score > 2. 7

• Aortic root dilatation thresholds: >40 mm in males, >36 mm in females, or an aortic size index (ASI) > 22 mm/m². 7

• The aortic height index (AHI) is now preferred over BSA‑based correction because it avoids underestimation in overweight individuals. 7

• The ESC 2024 Guidelines advise using the term “significant aortic dilation” with explicit diameter cut‑offs rather than “aneurysm,” since surgical indications often arise before reaching classic aneurysmal dimensions. 7

Risk Stratification Features (Beyond Diameter)

• Saccular morphology with a penetrating atherosclerotic ulcer confers high rupture risk. 5

• Uncontrolled resistant hypertension is a major adverse prognostic factor. 5

• Rapid aneurysm growth: ≥3 mm/year for the ascending aorta/arch; ≥10 mm/year (or ≥5 mm in 6 months) for descending thoracic and abdominal aneurysms. 5

• Indexed measurements (ASI or AHI) that relate aneurysm size to patient height/body size improve risk assessment, especially in patients at the extremes of body habitus. [5][7]

• Age‑adjusted upper normal limits for aortic diameter provide additional context for determining abnormal dilation. 5

All bullet points are derived from cited sources and reflect the ESC 2024 Guidelines or the referenced Circulation and European Heart Journal publications.

Classification and Risk Stratification of Aortic Aneurysms

Classification Systems

• Aortic aneurysms are organized by four complementary systems—anatomic location, etiology, morphology, and size‑based definitions—with the anatomic classification serving as the primary framework for clinical decision‑making and surgical planning. 8

Endovascular Planning Zones for Thoracoabdominal Aneurysms

• Thoracoabdominal aortic aneurysms (TAAAs) are mapped to landing zones numbered 0–11 for endovascular repair; Zone 0 encompasses the ascending aorta to the distal edge of the innominate artery, and the sequence progresses caudally to Zone 11 in the infrarenal abdominal aorta. 8

Dissection Risk Thresholds

• The relative risk of aortic dissection begins to rise noticeably when the aortic diameter reaches 4.0–4.4 cm and escalates dramatically at diameters of ≥ 4.5 cm, indicating that intervention thresholds should consider factors beyond absolute size alone. 8

Pathophysiology and Risk Factors of Aortic Aneurysms

Overall Pathophysiology

• Aortic aneurysms develop via distinct mechanisms: abdominal aortic aneurysms (AAA) arise mainly from medial degeneration driven by atherosclerotic risk factors and vasa vasorum hypoperfusion, whereas thoracic aortic aneurysms (TAA) result primarily from degenerative/atherosclerotic disease in older adults (≈ 80 % of cases) or from genetic/heritable conditions in younger adults (≈ 20 % of cases). 9

Abdominal Aortic Aneurysm (AAA) Mechanisms

• Medial degeneration is the core pathological process in AAA, characterized by thinning of the media and adventitia due to loss of vascular smooth‑muscle cells and extracellular‑matrix breakdown. 9
• Formation of an intraluminal thrombus promotes ongoing wall degradation through oxidative stress, smooth‑muscle cell apoptosis, proteolysis, and adventitial inflammation. 9

AAA Risk Factors

• Smoking is the strongest modifiable risk factor; lifetime risk of AAA is about 10 % in current smokers, with risk increasing proportionally to cumulative pack‑year exposure. 9
• Male sex markedly raises risk, with a lifetime AAA risk of roughly 8 % in men compared with substantially lower rates in women. 9
• Advanced age (≥ 65 years) is an independent risk factor; approximately two‑thirds of acute AAA events occur in individuals aged 75 years or older. 9
• A positive family history is present in 10–25 % of AAA patients; first‑degree relatives have a markedly higher lifetime prevalence (≈ 30 %). 9

Secondary AAA Etiologies

• Inflammatory aortitis (e.g., Takayasu arteritis, giant‑cell arteritis) can rarely give rise to AAA. 9

Factors Accelerating AAA Growth

• Both smoking and a positive family history speed up AAA expansion; the impact of smoking may be especially pronounced in women. 9

Thoracic Aortic Aneurysm (TAA) Genetic Associations

• A bicuspid aortic valve is linked to aneurysm formation in about 20–30 % of affected individuals, most often involving the aortic root. 9

Clinical Distinctions and Management Implications

• AAA and TAA have fundamentally different pathogeneses; therefore, screening and management strategies should be tailored separately for each type. 9
• Smoking cessation is critical because it influences both the development of AAA and its subsequent growth rate. 9
• Atherosclerotic risk models should not be directly applied to AAA, as the disease involves unique vasa‑vasorum hypoperfusion and inflammatory mechanisms beyond simple plaque formation. 9